Valgen Medtech Funding: $158M Raised, Series B (2021)
Valgen Medtech is based in Hangzhou, Zhejiang, China. It has raised $158M in total funding. Latest round: Series B.
Valgen Medtech funding overview
Valgen Medtech is based in Hangzhou, Zhejiang, China. Valgen Medtech has raised $158M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Valgen Medtech runs through 2021; nothing later has been disclosed. Investors on record include BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital. 5 distinct backers are named across the disclosed rounds.
Valgen Medtech at a glance
Total raised
$158M
Latest round
Series B
Latest round date
May 2021
Headquarters
Hangzhou, Zhejiang, China
Notable investors
BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital
Frequently asked about Valgen Medtech funding
How much has Valgen Medtech raised?
Valgen Medtech has raised $158M in total disclosed funding across the rounds on record.
Who has invested in Valgen Medtech?
BioTrack Capital, Shanghai INT Medical Instruments, Ascendum Capital, China Life Private Equity, DCP Capital are named among the investors backing Valgen Medtech.
What was the latest Valgen Medtech funding round?
The most recent disclosed round is a Series B, announced in May 2021.
Where is Valgen Medtech based?
Valgen Medtech is based in Hangzhou, Zhejiang, China.
When did Valgen Medtech last raise?
The last disclosed Valgen Medtech round closed in May 2021 at Series B.
Round data for Valgen Medtech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.
